As we say goodbye to 2024, The Hepatitis Fund is reflecting on the incredible progress we’ve made — progress that wouldn’t be possible without your support.
From launching new multi-year funding opportunities for Asian and African organisations to signing several new agreements with international partners, The Hepatitis Fund has been busy driving collaboration and strengthening global efforts to eliminate viral hepatitis as a threat to public health.
As always, we remain committed to achieving a world where no child is born with viral hepatitis and where people living with hepatitis have access to equitable treatment and care – no matter where they are. Your support has made it possible for us to continue advancing this critical work, bringing us closer to a world free from viral hepatitis.
From all of us at The Hepatitis Fund, thank you!
Some of our project highlights
Pioneering innovative approaches to tackle hepatitis B, HIV, and syphilis among pregnant women in Vietnam
Each year, over 180,000 newborn babies in the Asia-Pacific region are newly infected by hepatitis B through mother-to-child transmission.
The Hepatitis Fund, PATH, and the City of Geneva recently partnered on an innovative approach to dealing with hepatitis B, HIV, and syphilis in Vietnam. Launched in late 2021, the 3-year project continues to demonstrate that early screening and treatment for pregnant women can effectively prevent mother-to-child transmission while offering scalable and cost-efficient solutions that work for local communities. Learn more
Preventing mother-to-child transmission of hepatitis B in Rwanda
In Rwanda, roughly 10,000 newborns are at risk of being exposed to hepatitis B at birth every year. To address this, The Hepatitis Fund, CHAI, and the Canton of Geneva co-funded a project to scale up hepatitis B screening, diagnosis, and antiviral treatment among pregnant women in Rwanda.
In 2024, the participating healthcare centres have provided hepatitis B screening, vaccination, and/or antiviral treatment to over 90% of mothers, newborns, and people living with hepatitis B seeking care. The project is on track to screen over 240,000 pregnant women and drastically improve vaccine coverage for newborns. Learn more
On the road to eliminating viral hepatitis across Asia-Pacific
In 2024, The Hepatitis Fund participated in numerous high-level meetings across the Asia-Pacific region, working with policymakers, experts, and community organisations to prioritise efforts to eliminate hepatitis as a public health threat in the region.
Such meetings included the first Summit of the APAC Liver Disease Alliance in Bangkok, Thailand, the WHO’s National Programme Manager’s Meeting for Strengthening implementation of integrated service delivery to end AIDS, viral hepatitis and STIs in the South-East Asia Region, Bangkok, Thailand, and several other high-level meetings held in Indonesia, Vietnam, India, Philippines, Singapore, and more.
Partnering with the Muslim World League to reduce the burden of hepatitis in Africa
Even though a hepatitis B vaccine, testing and effective treatment are available, access to these life-saving interventions across Africa remains limited due to a lack of resources and political will.
In August, The Hepatitis Fund met with the Muslim World League to explore solutions to significantly reduce the burden of viral hepatitis in Africa. It signed a memorandum of understanding to collaborate on future hepatitis projects in Somalia, Kenya, and other countries.
The Hepatitis Fund on the international stage
World Hepatitis Summit 2024, Lisbon
In April, The Hepatitis Fund attended the World Hepatitis Summit 2024 in Lisbon, where we collaborated with world-leading hepatitis experts and community advocates. Learn more
The London Global Cancer Week, London
In November, The Hepatitis Fund and The Lancet Gastroenterology & Hepatology hosted “Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination”, addressing the role that viral hepatitis elimination plays in tackling the global burden of liver cancer.
AVPN Global Conference 2024 , Abu Dhabi
Under the theme, “One Asia, One Future”, in April The Hepatitis Fund attended the AVPN Global Conference in Abu Dhabi, which explored ways to increase hepatitis awareness and action throughout Asia. Learn more
World Hepatitis Day, Geneva
The Hepatitis Fund participated in several events during World Hepatitis Day in July, raising awareness about hepatitis and advocating for increased funding worldwide. Learn more
Forging new partnerships
In July 2024, The Hepatitis Fund started an exciting new partnership with ACCESS Health International to amplify our impact and strengthen collaboration towards eliminating hepatitis. This strategic partnership will focus on raising awareness, sharing expertise and developing and securing funding for impactful initiatives.
Join us in ending viral hepatitis!
Every 30 seconds someone loses their life to viral hepatitis. It doesn’t have to be this way. Whether it’s in the Asia Pacific region or East Africa, The Hepatitis Fund makes focused investments that work to close real gaps in the prevention, treatment and care of viral hepatitis.
When you donate to The Hepatitis Fund, you aren’t just saving lives today. You’re making a strategic investment designed to accelerate progress towards a hepatitis-free tomorrow.
We have the opportunity, now is the time to act.
